Bio Green Med Solution, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Bio Green Med Solution, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $0 | Mar 30, 2018 |
| FY2017 | Dec 31, 2016 | $843.0K | Mar 30, 2018 |
| FY2016 | Dec 31, 2015 | $1.94M | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $1.73M | Mar 29, 2016 |
| FY2014 | Dec 31, 2013 | $1.08M | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | $69.0K | Mar 26, 2014 |
| FY2011 | Dec 31, 2011 | $699.0K | Mar 30, 2012 |
| FY2012 | Dec 31, 2010 | $112.0K | Apr 1, 2013 |
| FY2011 | Dec 31, 2009 | $911.0K | Mar 30, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($11.21M) | Nov 26, 2025 |
| FY2024 | Dec 31, 2023 | ($22.56M) | Nov 26, 2025 |
| FY2023 | Dec 31, 2022 | ($21.20M) | Mar 21, 2024 |
| FY2022 | Sep 30, 2022 | ($5.10M) | Nov 29, 2023 |
| FY2022 | Jun 30, 2022 | ($4.58M) | Nov 29, 2023 |
| FY2022 | Dec 31, 2021 | ($18.46M) | Nov 29, 2023 |
| FY2022 | Sep 30, 2021 | ($4.76M) | Nov 29, 2023 |
| FY2021 | Dec 31, 2020 | ($8.45M) | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | ($7.83M) | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | ($7.29M) | Mar 5, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($12.00M) | Nov 26, 2025 |
| FY2024 | Dec 31, 2023 | ($25.45M) | Nov 26, 2025 |
| FY2023 | Dec 31, 2022 | ($27.66M) | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | ($22.39M) | Nov 29, 2023 |
| FY2022 | Sep 30, 2021 | ($5.70M) | Nov 29, 2023 |
| FY2021 | Dec 31, 2020 | ($10.64M) | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | ($9.68M) | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | ($9.55M) | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | ($9.49M) | Mar 28, 2019 |
| FY2017 | Dec 31, 2016 | ($14.15M) | Mar 30, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $4.09M | Nov 26, 2025 |
| FY2024 | Dec 31, 2023 | $8.81M | Nov 26, 2025 |
| FY2023 | Dec 31, 2022 | $28.05M | Mar 21, 2024 |
| FY2022 | Sep 30, 2022 | $31.57M | Nov 29, 2023 |
| FY2022 | Jun 30, 2022 | $35.90M | Nov 29, 2023 |
| FY2022 | Mar 31, 2022 | $40.18M | Nov 29, 2023 |
| FY2022 | Dec 31, 2021 | $43.14M | Nov 29, 2023 |
| FY2022 | Sep 30, 2021 | $45.29M | Nov 29, 2023 |
| FY2021 | Dec 31, 2020 | $36.80M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $15.31M | Mar 1, 2021 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $6.27M | Nov 26, 2025 |
| FY2024 | Dec 31, 2023 | $8.20M | Nov 26, 2025 |
| FY2023 | Dec 31, 2022 | $7.62M | Mar 21, 2024 |
| FY2022 | Sep 30, 2022 | $4.58M | Nov 29, 2023 |
| FY2022 | Jun 30, 2022 | $5.26M | Nov 29, 2023 |
| FY2022 | Mar 31, 2022 | $6.34M | Nov 29, 2023 |
| FY2022 | Dec 31, 2021 | $5.44M | Nov 29, 2023 |
| FY2022 | Sep 30, 2021 | $3.70M | Nov 29, 2023 |
| FY2021 | Dec 31, 2020 | $3.54M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $3.61M | Mar 1, 2021 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($2.17M) | Nov 26, 2025 |
| FY2024 | Dec 31, 2023 | $607.0K | Nov 26, 2025 |
| FY2024 | Dec 31, 2022 | $15.94M | Nov 26, 2025 |
| FY2022 | Sep 30, 2022 | $22.50M | Nov 29, 2023 |
| FY2022 | Jun 30, 2022 | $29.53M | Nov 29, 2023 |
| FY2022 | Mar 31, 2022 | $33.84M | Nov 29, 2023 |
| FY2023 | Dec 31, 2021 | $37.69M | Mar 21, 2024 |
| FY2022 | Sep 30, 2021 | $41.59M | Nov 29, 2023 |
| FY2022 | Dec 31, 2020 | $33.26M | Nov 29, 2023 |
| FY2021 | Dec 31, 2019 | $11.70M | Mar 30, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | (504) | Nov 26, 2025 |
| FY2024 | Dec 31, 2023 | (6,419) | Nov 26, 2025 |
| FY2022 | Dec 31, 2022 | (1) | Mar 8, 2023 |
| FY2022 | Dec 31, 2021 | (2) | Nov 29, 2023 |
| FY2022 | Sep 30, 2021 | 0 | Nov 29, 2023 |
| FY2021 | Dec 31, 2020 | (3) | Mar 30, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | (504) | Nov 26, 2025 |
| FY2024 | Dec 31, 2023 | (6,419) | Nov 26, 2025 |
| FY2023 | Dec 31, 2022 | (27) | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | (2) | Nov 29, 2023 |
| FY2022 | Sep 30, 2021 | 0 | Nov 29, 2023 |
| FY2021 | Dec 31, 2020 | (3) | Mar 30, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $3.14M | Nov 26, 2025 |
| FY2024 | Dec 31, 2023 | $3.38M | Nov 26, 2025 |
| FY2023 | Dec 31, 2022 | $18.35M | Mar 21, 2024 |
| FY2022 | Dec 31, 2021 | $36.56M | Nov 29, 2023 |
| FY2021 | Dec 31, 2020 | $33.41M | Mar 30, 2022 |
| FY2020 | Dec 31, 2019 | $11.89M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $17.50M | Mar 5, 2020 |
| FY2018 | Dec 31, 2017 | $23.91M | Mar 28, 2019 |
| FY2018 | Dec 31, 2016 | $16.52M | Mar 28, 2019 |
| FY2017 | Dec 31, 2015 | $20.44M | Mar 30, 2018 |